pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects

ALBUQUERQUE, L., V. SINCARI, A. JAGER, J. KUCKA, J. HUMAJOVA, J. PANKRAC, P. PARAL, T. HEIZER, O. JANOUSKOVA, I. DAVIDOVICH, Y. TALMON, P. POUCKOVA, P. STEPANEK, L. SEFC, M. HRUBY, F. GIACOMELLI, A. JAGER: pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects. Journal of Controlled Release : Official Journal of the Controlled Release Society. 2021, 332, 529-538, ISSN: 0168-3659, PMID: 33716094.